CLJXL - 045, HALON 1301

Product Identification

Product ID:045, HALON 1301
MSDS Date:09/01/1990
FSC:6830
NIIN:01-284-5852
Status Code:A
MSDS Number: CLJXL

Responsible Party
GREAT LAKES CHEMICAL CORP
1801 HWY 52 NW
WEST LAFAYETTE, IN 47996-2200
US

Emergency Phone: (501) 862-5141

Info Phone: 765-497-6100/800-949-5167

Preparer: RESEARCH SERVICES DEPT

Cage: 2E394

Contractor
KEYSTONE FIRE PROTECTION CO.
MONTGOMERYVILLE, PA 18936 US

Telephone: 215-641-0100/ FAX 215-641-9638

Cage: 1U693

Ingredients

BROMOTRIFLUOROMETHANE

CAS: 75-63-8

RTECS: PA5425000

OSHA PEL 6100 MG/M3;1000 PPM

ACGIH TLV: 6090 MG/M3;1000 PPM

Hazards

LD50 LC50 Mixture:LC50 RAT >800,000 PPM FOR 4 HRS.
Routes of Entry: Inhalation:YES Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:HALON 1301 HAS ANESTHETIC AND CARDIAC
EFFECTS IN HUMANS AT CONCENTRATIONS ABOVE 10% BY VOLUME,
CONCENTRATIONS BELOW 10% ARE CONSIDERED SAFE FOR 0-5 MINUTE
EXPOSURES. HALON 1301 IS CLASSIFIED AS GROUP 6 (LEAST TOXIC) IN
THE UNDERWRITERS LABORATORIES CLASSIFICATION OF COMPARATIVE LIFE
HAZARDS OF FIRE EXTINGUISHING AGENTS. SMOKING IN AREAS WHERE THIS
CHEMICAL IS RELEASED CAN CAUSE FORMATION OF TOXIC & IRRITATING
HALOGENS AND HLOGEN ACIDS WHICH COULD BE INHALED WITH THE SMOKE.
Explanation of Carcinogenicity:PRODUCT IS NON-MUTAGENIC IN THE AMES
TEST.
Effects of Overexposure:THE ANESTHETIC EFFECT OF HALON 1301 AT LEVELS
BELOW 10% IS SIMILAR TO A FEELING OF MILD INTOXICATION. ANESTHETIC
EFFECTS END RAPIDLY AFTER EXPOSURE IS TERMINATED. PROLONGED
EXPOSURE TO CONCENTRATIONS ABOVE 10% (15-20%) MAY LEAD TO
UNCONSCIOUSNESS AND POSSIBLY DEATH. INHALATION OF PRODUCT & ITS
DECOMPOSITION PRODUCTS CAN CAUSE CLOUDING OF CONTACT LENSES.
Medical Cond Aggravated by Exposure:CARDIAC CONDITIONS MAY BE
AGGRAVATED BY OVEREXPOSURE.

First Aid

First Aid:INHALATION: REMOVE PERSON TO FRESH AIR; IF NOT BREATHING,
GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE
OXYGEN. GET MEDICAL ATTENTION. SKIN: FLUSH WITH WATER. GET MEDICAL
ATTENTION IF F ROSTBITE OCCURS. EYES: FLUSH WITH WATER. GET MEDICAL
ATTENTION. NOTE: EPINEPHRINE IS CONTRAINDICATED IN THE TREATMENT OF
OVER-EXPOSURE TO THIS PRODUCT.

Fire Fighting

Flash Point:NON-FLAMMABLE
Extinguishing Media:HALON 1301 IS A FIRE EXTINGUISHING AGENT. USE WATER
SPRAY TO COOL CYLINDERS INVOLVED IN FIRES. USE MEDIA SUITABLE FOR
FLAMMABLE MATERIAL IN THE AREA.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS.
Unusual Fire/Explosion Hazard:PREDOMINANT DECOMPOSITION PRODUCTS ARE
HYDROGEN FLUORIDE AND HYDROGEN BROMIDE IN FIRE SITUATIONS. THE
PRODUCTS ARE IRRITATING AND POTENTIALLY TOXIC IF FIRE
EXTINGUISHMENT IS DELAYED. ABOVE 1000F, HALO N 1301 MAY RELEASE
HYDROGEN FLUORIDE, HYDROGEN BROMIDE, CARBONYL FLUORIDE AND CARBONYL
BROMIDE.

Accidental Release

Spill Release Procedures:EVACUATE AREA. WEAR SELF-CONTAINED BREATHING
APPARATUS, VENTILATE ENCLOSED AREAS IN CASE OF DISCHARGE.

Handling

Handling and Storage Precautions:PROTECT CYLINDERS FROM PHYSICAL
DAMAGE. STORAGE TEMPERATURE SHOULD NOT EXCEED 125F. CYLINDERS
SHOULD BE SECURED FOR STORAGE WITH VALVE PROTECTION CAP IN PLACE.
Other Precautions:DO NOT SMOKE OR WEAR CONTACT LENSES WHERE THIS
PRODUCT IS BEING USED.

Exposure Controls

Respiratory Protection:WEAR NIOSH APPROVED, SELF-CONTAINED BREATHING
APPARATUS AT CONCENTRATIONS GREATER THAN 10,000 PPM AS RECOMMENDED
BY NIOSH. CONSULT ANSI STANDARD AND OSHA REGULATIONS CONCERNING THE
USE OF RESPIRATORY EQUIPMENT. AVOID PROLONGED EXPOSURE TO
EXCESSIVE CONCENTRATIONS.
Ventilation:LOCAL EXHAUST-MAERIAL TRANSFER AND HANDLING SHOULD BE
CONDUCTED WITH AN EXHAUST SYSTEM. MECHANICAL-ALL INDOOR AREAS
SHOULD BE WELL VENTILATED. SPECIAL-NONE
Protective Gloves:LINED NEOPRENE OR LEATHER IF FROSTBITE IS A
POSSIBILITY
Eye Protection:CHEMICAL SAFETY GOGGLES IF FROSTBITE IS A POSSIBILITY.
DO NOT WEAR CONTACT LENS
Other Protective Equipment:NONE
Work Hygienic Practices:DETERMINE THAT PIPING IS EMPTY BEFORE DOING
MAINTENANCE WORK. PERIODICALLY CHECK CYLINDER TO ENSURE VALVES ARE
NOT LEAKING.
Supplemental Safety and Health

Chemical Properties

HCC:G3
Boiling Pt:=-57.6C, -72.F
Melt/Freeze Pt:=-167.6C, -270.F
Vapor Pres:6200 AT 0C
Vapor Density:5.1
Spec Gravity:1.57 AT 20C
Evaporation Rate & Reference:NOT AVAILABLE
Solubility in Water:0.03% BY WEIGHT
Appearance and Odor:ODORLESS, COLORLESS GAS

Stability

Stability Indicator/Materials to Avoid:YES
ACTIVE METALS, FIRES OF METAL HYDRIDES, AND MATERIAL CONTAINING OWN
OXYGEN. PRODUCT WILL NOT EXTINGUISH FIRES OF THESE MATERIALS.
PRODUCT MAY DEGRADE CERTAIN POLYMERIC MATERIALS.
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:IN THE PRESENCE OF FLAMES OR HOT
SURFACES: HYDROGEN FLUORIDE, HYDROGEN BROMIDE, BROMINE, CARBONYL
FLUORIDE, AND CARBONYL BROMIDE. SMOKING CAN CAUSE FORMATION OF
THESE CHEMCIALS AND MUST BE AVOIDED IN
Conditions to Avoid Polymerization:WILL NOT OCCUR.

Disposal

Waste Disposal Methods:RETURN CYLINDERS TO GREAT LAKES CHEMICAL
CORPORATION, EL DORADO, ARKANSAS.

Toxicology

Toxicological Information:APPROXIMATE LETHAL CONCENTRATION OF HALON
1301 TO THE RAT IS GREATER THAN 800,000 PPM FOR 15 MINUTES. THE
ACUTE INHALATION LC50 WITH RATS IS GREATER THAN 800,000 PPM FOR 4
HOURS. THE COMPOUND IS REPOR TED TO BE NON-MUTAGENIC IN THE AMES
TEST. HALON 1301 HAS ANESTHETIC AND CARDIAC EFFECTS IN HUMANS AT
CONCENTRATIONS ABOVE 10% BY VOLUME, CONCENTRATIONS BELOW 10% ARE
CONSIDERED SAFE FOR 0-5 MINUTE EXP OSURES.

Transport

Transport Information:DOT: COMPRESSED GAS, N.O.S.
(BROMOTRIFLUOROMETHANE) NON-FLAMMABLE GAS, UN 1956. EXPORT:
BROMOTRIFLUOROMETHANE, NON-FLAMMABLE GAS, UN 1009, IMO CLASS 2.2.

Regulatory

SARA Title III Information:THIS CHEMICAL IS SUBJECT TO THE REPORTING
REQUIREMENTS OF SECTION 313 OF TITLE III OF SUPERFUND AND 40 CFR
372.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.